UNH - Unitedhealth Group Inc Stock Analysis
Unitedhealth Group Inc (UNH) is a publicly traded company listed on the NYSE. It operates in the Healthcare Plans industry, part of the broader Healthcare sector. The company has a market capitalization of 302.09B, generates annual revenue of 435.16B, and reports net income of 17.59B. As of the latest data, the stock is trading at 333.49 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock appears reasonably valued, potentially indicating balanced risk and return. The PEG ratio is below 1, which may indicate the stock is undervalued relative to its growth potential. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The stock offers a moderate dividend yield (2.58%), which may appeal to income-focused investors. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Hold (3.73), indicating current market sentiment. Institutional ownership is reported at 84.08%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of -45.20%, trading within a 52-week range of 234.60 - 622.83.
UNH - Unitedhealth Group Inc
333.49
Analyst Consensus
Hold 3.73
UNH – Analyst Rating Summary
- Strong Buy: 6
- Buy: 16
- Hold: 8
- Sell: 2
- Strong Sell: 1
- Total Analysts: 33
| Index: | DJIA, S&P 500 | P/E: | 17.40 | EPS (ttm): | 19.16 | Insider Own: | 0.20% | Shs Outstand: | 906.00M | Perf Week: | 1.15% |
| Market Cap: | 302.09B | Forward P/E: | 18.83 | EPS next Y: | 17.71 | Insider Trans: | -0.03% | Shs Float: | 904.00M | Perf Month: | 0.80% |
| Income(ttm): | 17.59B | PEG: | - | EPS next Q: | 2.11 | Inst Own: | 84.08% | Short Float: | 1.36% | Perf Quarter: | 5.74% |
| Revenue(ttm): | 435.16B | P/S: | 0.69 | EPS this Y: | -40.99% | Inst Trans: | -2.68% | Short Ratio: | 1.25 | Perf Half Y: | 12.73% |
| Book/sh: | 105.73 | P/B: | 3.15 | EPS next Y: | 8.49% | ROA: | 5.72% | Short Interest: | 12.33M | Perf Year: | -45.20% |
| Cash/sh: | - | P/C: | - | EPS next 5Y: | -8.89% | ROE: | 18.48% | 52W Range: | 234.60 - 622.83 | Perf YTD: | -34.07% |
| Dividend Est.: | 8.59 (2.58%) | P/FCF: | 17.39 | EPS past 3/5Y: | -4.99% 1.60% | ROIC: | 10.46% | 52W High: | 622.83 -46.46% | Beta: | 0.42 |
| Dividend TTM: | 8.62 (2.58%) | Quick Ratio: | - | Sales past 3/5Y: | 11.65% 10.57% | Gross Margin: | - | 52W Low: | 234.60 42.15% | Perf 5Y: | -1.32% |
| Dividend Ex-Date: | Dec 08, 2025 | Current Ratio: | 0.82 | EPS Y/Y TTM: | 24.25% | Oper. Margin: | 6.06% | RSI (14): | 51.97 | Volatility: | 2.77% 2.80% |
| Employees: | 400000 | Debt/Eq: | 0.84 | Sales Y/Y TTM: | 10.48% | Profit Margin: | 4.04% | Recom: | 1.86 | Target Price: | 394.71 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.76 | EPS Q/Q: | -60.28% | Payout: | 52.75% | Rel Volume: | 0.81 | Prev Close: | 339.71 |
| Sales Surprise: | 0.12% | EPS Surprise: | 4.46% | Sales Q/Q: | 12.24% | Earnings: | Oct 28 BMO | Avg Volume: | 9.90M | Price: | 333.49 |
| SMA20: | 2.79% | SMA50: | -2.61% | SMA200: | -8.07% | Undervalued: 18.36% | Volume: | 8,042,157 | Change: | -1.83% | |
Graham Classic formula value: -159.66
(P/E=8 * 1g) Min value: -15.31
(current P/E * 2g) Max value: -6.54
Average value: -60.5
About Unitedhealth Group Inc
UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.